These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study. Kane JM, Peters-Strickland T, Baker RA, Hertel P, Eramo A, Jin N, Perry PP, Gara M, McQuade RD, Carson WH, Sanchez R. J Clin Psychiatry; 2014 Nov; 75(11):1254-60. PubMed ID: 25188501 [Abstract] [Full Text] [Related]
4. Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia. Citrome L, Du Y, Risinger R, Stankovic S, Claxton A, Zummo J, Bose A, Silverman BL, Ehrich EW. Int Clin Psychopharmacol; 2016 Mar; 31(2):69-75. PubMed ID: 26517202 [Abstract] [Full Text] [Related]
13. Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study. Xiao L, Zhao Q, Li AN, Sun J, Wu B, Wang L, Zhang H, Zhang R, Li K, Xu X, Liu T, Zhang W, Xie S, Xu X, Tan Y, Zhang K, Zhang H, Guan N, Xian M, Uki M, Wang G. Psychopharmacology (Berl); 2022 Jan; 239(1):243-251. PubMed ID: 34989824 [Abstract] [Full Text] [Related]
18. Effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychotics. Peters-Strickland T, Zhao C, Perry PP, Eramo A, Salzman PM, McQuade RD, Johnson BR, Sanchez R. CNS Spectr; 2016 Dec; 21(6):460-465. PubMed ID: 27531181 [Abstract] [Full Text] [Related]